Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)
Clinical trial NCT03668600 · TERMINATED
Trial details
- NCT number
- NCT03668600
- Sponsor
- Naurex, Inc, an affiliate of Allergan plc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-23
- Primary completion
- 2019-07-03
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.